FAQ

FNIP1 gene

Known as: KIAA1961, FNIP1, folliculin interacting protein 1 
 

Topic mentions per year

Topic mentions per year

2012-2017
01220122017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway.
Obesity is often accompanied by decreases in the proportion of skeletal muscle slow-twitch fibers and insulin sensitivity… (More)
  • table 1
Is this relevant?
Review
2017
Review
2017
Control of B lymphocyte development and functions by the mTOR signaling pathways.
Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase originally discovered as the molecular target of the… (More)
Is this relevant?
2016
2016
Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity.
Folliculin (FLCN) is a tumor-suppressor protein mutated in the Birt-Hogg-Dubé (BHD) syndrome, which associates with two… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Birt-Hogg-Dubé syndrome is an autosomal dominantly inherited disease that predisposes patients to develop fibrofolliculoma, lung… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Folliculin (FLCN)-interacting proteins 1 and 2 (FNIP1, FNIP2) are homologous binding partners of FLCN, a tumor suppressor for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
Since the hallmark dermatologic features of Birt–Hogg–Dubé (BHD) syndrome were first described by three Canadian physicians in… (More)
  • figure 1
  • figure 2
Is this relevant?